
STAT+: After late start, Eli Lilly has the momentum in battle for $30 billion weight loss market
SAN DIEGO — It was Novo Nordisk’s Ozempic and Wegovy that set off a new era in obesity medicine, delivering unprecedented levels of weight loss and working its way into popular culture, inescapable ads, and […]